Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Interleukin 2
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Function == IL-2 has essential roles in key functions of the immune system, [[Central tolerance|tolerance]] and [[Immunity (medical)|immunity]], primarily via its direct effects on [[T cells]]. In the [[thymus]], where T cells mature, it prevents [[autoimmune diseases]] by promoting the [[Cellular differentiation|differentiation]] of certain immature T cells into [[regulatory T cells]], which suppress other T cells that are otherwise primed to attack normal healthy cells in the body. IL-2 enhances [[Activation-induced cell death|activation-induced cell death (AICD)]].<ref name=":0" /> IL-2 also promotes the differentiation of T cells into [[effector T cells]] and into [[memory T cells]] when the initial T cell is also stimulated by an [[antigen]], thus helping the body fight off infections.<ref name="Liao_2011"/> Together with other polarizing cytokines, IL-2 stimulates naive CD4<sup>+</sup> T cell differentiation into [[Th1 cell|T<sub>h</sub>1]] and [[Th2 cell|T<sub>h</sub>2]] lymphocytes while it impedes differentiation into [[T helper 17 cell|T<sub>h</sub>17]] and folicular T<sub>h</sub> lymphocytes.<ref>{{cite journal | vauthors = Liao W, Lin JX, Leonard WJ | title = Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy | journal = Immunity | volume = 38 | issue = 1 | pages = 13β25 | date = January 2013 | pmid = 23352221 | doi = 10.1016/j.immuni.2013.01.004 | pmc = 3610532 }}</ref><ref name="pmid30089912">{{cite journal | vauthors = Spolski R, Li P, Leonard WJ | title = Biology and regulation of IL-2: from molecular mechanisms to human therapy | journal = [[Nature Reviews Immunology]] | volume = 18 | issue=10 | pages = 648β659 |date=2018 | doi = 10.1038/s41577-018-0046-y | pmid = 30089912| s2cid = 51939991 }}</ref> IL-2 increases the cell killing activity of both [[natural killer cell]]s and [[cytotoxic T cell]]s.<ref name="pmid30089912" /> Its expression and secretion is tightly regulated and functions as part of both transient positive and negative [[Feedback#Biology|feedback loops]] in mounting and dampening immune responses. Through its role in the development of T cell immunologic memory, which depends upon the expansion of the number and function of antigen-selected T cell clones, it plays a key role in enduring [[cell-mediated immunity]].<ref name="Liao_2011" /><ref name="Malek_2010">{{cite journal | vauthors = Malek TR, Castro I | title = Interleukin-2 receptor signaling: at the interface between tolerance and immunity | journal = Immunity | volume = 33 | issue = 2 | pages = 153β65 | date = August 2010 | pmid = 20732639 | pmc = 2946796 | doi = 10.1016/j.immuni.2010.08.004 }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)